Acceleron completes follow-on

Acceleron Pharma Inc. (NASDAQ: XLRN), Cambridge, Mass. Business: Musculoskeletal, Hematology, Cancer Date completed: 1/22/14 Type: Follow-on Raised: $120 million Shares: 2.4 million Price: $50 Shares ...